Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Day 1 The World Orphan Drug Congress – Geneva

Authored by Karl Simpson Well, the pharma industry’s rare disease pioneers gather again this week for the World Orphan Drug Congress in Geneva. It is a two day seminar that focuses on three separate tracks, Clinical Development, Market Access/Pricing and … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

NPS Pharmaceuticals gets ready to launch gastro orphan drug

Authored by Karl Simpson In recent weeks, Liftstream has featured a range of articles in the rare disease and orphan drug area. One of the companies particularly catching our eye right now is NPS Pharmaceuticals, led by CEO Dr. Francois … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

November edition of the Liftstream Life Science Newsletter

This months edition contains: Industry highlights from the past month A special feature on the London Biotechnology Cluster Articles looking at the role of Adaptive trial design in orphan drug development and Creating Shareholder Value Through Effective Clinical and Regulatory … Continue reading

Posted in Pharmaceutical business | Tagged , , | Leave a comment

Adaptive Clinical Trials in Orphan Drug Development

Authored by James Sheppard The global pharmaceutical market is currently facing one of the toughest challenges to date. With blockbuster drugs coming off patent and diminishing pipelines big pharma are looking towards alternatives to provide renewed revenue. One avenue being … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Shareholder Value Creation Through Effective Clinical and Regulatory Management

Authored by Karl Simpson This past week we saw the impact which positive clinical data can have on the share price of a biotech or pharma company, as rare disease specialist BioMarin reached lifetime highs as it reported on its … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap